Tumor Prevention and Genetics

[1]  G. Eklund,et al.  Randomized study of mammography screening — preliminary report on mortality in the stockholm trial , 1991, Breast Cancer Research and Treatment.

[2]  H. Gensler.  Prevention byα-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation , 2005, Journal of Cancer Research and Clinical Oncology.

[3]  Matthijs Oudkerk,et al.  First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.

[4]  E. Weiderpass,et al.  Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement , 1999, Cancer Causes & Control.

[5]  L. Holmberg,et al.  Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450,000 women , 1997, Breast Cancer Research and Treatment.

[6]  L. Kolonel.  Nutrition and prostate cancer , 2004, Cancer Causes & Control.

[7]  J. Lim.  Interval Breast Cancer , 2003 .

[8]  M. Buyse,et al.  Is FOB screening really the answer for lowering mortality in colorectal cancer? , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[9]  S. Feig.  How reliable is the evidence for screening mammography? , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[10]  A. Miller.  Is mammography screening for breast cancer really not justifiable? , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[11]  T. To,et al.  The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years , 2002, Annals of Internal Medicine.

[12]  V. Bramwell,et al.  Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Feig,et al.  Effect of service screening mammography on population mortality from breast carcinoma , 2002, Cancer.

[14]  L. Tabár,et al.  The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties , 2002, Cancer.

[15]  S. Lam,et al.  A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. , 2002, Journal of the National Cancer Institute.

[16]  S. Piantadosi,et al.  Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .

[17]  L. Lipton,et al.  Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Gøtzsche,et al.  Mammographic screening: no reliable supporting evidence? , 2002, The Lancet.

[19]  K. Kinzler,et al.  Detection of proximal colorectal cancers through analysis of faecal DNA , 2002, The Lancet.

[20]  A. Buzdar.  Superior efficacy of letrozole versus tamoxifen as first-line therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Xìao-chun Xu.  COX-2 inhibitors in cancer treatment and prevention, a recent development. , 2002, Anti-cancer drugs.

[22]  P. Bunn,et al.  ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. , 2002, Seminars in oncology.

[23]  K. Kinzler,et al.  Detection of APC mutations in fecal DNA from patients with colorectal tumors. , 2002, The New England journal of medicine.

[24]  S. Gluck.  Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor–positive advanced breast carcinoma , 2002, Cancer.

[25]  K. Kinzler,et al.  Small changes in expression affect predisposition to tumorigenesis , 2002, Nature Genetics.

[26]  D. Alberts,et al.  Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  A. Miller.  Screening for breast cancer with mammography , 2001, The Lancet.

[28]  C. Albrecht,et al.  Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status. , 2001, International journal of oncology.

[29]  G Rennert,et al.  Population colorectal cancer screening with fecal occult blood test. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  Richard Horton,et al.  Screening mammography—an overview revisited , 2001, The Lancet.

[31]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[32]  S. Madersbacher,et al.  Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[33]  M. Spitz,et al.  Lung cancer chemoprevention: an integrated approach. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  G Bartsch,et al.  Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. , 2001, Urology.

[35]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[36]  A. Zlotta,et al.  Nutrition and prostate cancer: evidence or suspicion? , 2001, Urology.

[37]  S. Lippman,et al.  Lipoxygenase modulation to reverse carcinogenesis. , 2001, Cancer research.

[38]  L. Nyström,et al.  Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer , 2001, Journal of medical screening.

[39]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  G. Petersen,et al.  AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.

[41]  G. T. Bowden,et al.  Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes , 2001, Oncogene.

[42]  N. Baxter.  Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[43]  S. Duffy,et al.  Interpretation of the breast screening trials: a commentary on the recent paper by Gøtzsche and Olsen. , 2001, Breast.

[44]  H. Inoue,et al.  Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. , 2001, Cancer research.

[45]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[46]  L. Stark,et al.  Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  P J Catalano,et al.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.

[48]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[49]  S. Lippman,et al.  Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  P. Peltomäki,et al.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer. , 2001, Human molecular genetics.

[51]  A. Nicholson,et al.  Reproducibility of the WHO/IASLC grading system for pre‐invasive squamous lesions of the bronchus: a study of inter‐observer and intra‐observer variation , 2001, Histopathology.

[52]  E. Banks.  Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review , 2001, Journal of medical screening.

[53]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[54]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[55]  S. Fischer,et al.  Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice. , 2001, Carcinogenesis.

[56]  J O Barentsz,et al.  Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[57]  J. Minna,et al.  Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.

[58]  B Palcic,et al.  Detection and localization of early lung cancer by fluorescence bronchoscopy , 2000, Cancer.

[59]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[60]  F. Liebens,et al.  Effect of screening programme on mortality from breast cancer , 2000, BMJ : British Medical Journal.

[61]  L M Schuman,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[62]  R. Niles,et al.  Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. , 2000, Nutrition.

[63]  C. Eng.  Will the real Cowden syndrome please stand up: revised diagnostic criteria , 2000, Journal of medical genetics.

[64]  J. Herman,et al.  Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.

[65]  A. Miller,et al.  Organized breast cancer screening programs in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[66]  I. Olivotto,et al.  Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[67]  I Tomlinson,et al.  Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. , 2000, Human molecular genetics.

[68]  A. Miller,et al.  Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. , 2000, Journal of the National Cancer Institute.

[69]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[70]  S. Lippman,et al.  N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[71]  H. Adami,et al.  More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[72]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[73]  E. Smit,et al.  Observer Variability in Histopathologic Reporting of Bronchial Biopsy Specimens: Influence on the Results of Autofluorescence Bronchoscopy in Detection of Preinvasive Bronchial Neoplasia , 2000 .

[74]  Weiya Ma,et al.  Inhibition of Ultraviolet B–Induced AP‐1 Activation by Theaflavins From Black Tea , 2000, Molecular carcinogenesis.

[75]  A. Ackerman,et al.  The nature of solar keratosis: a critical review in historical perspective. , 2000, Journal of the American Academy of Dermatology.

[76]  L. Tabár,et al.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.

[77]  M. Pike,et al.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[78]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[79]  O. Dalesio,et al.  EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. , 2000, Journal of the National Cancer Institute.

[80]  G. Omenn.  Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches. , 2000, Journal of the National Cancer Institute.

[81]  Lisa M. Schwartz,et al.  Are increasing 5-year survival rates evidence of success against cancer? , 2000, JAMA.

[82]  E. Smit,et al.  Outcome of bronchial carcinoma in situ. , 2000, Chest.

[83]  K. Heinimann,et al.  Genetics of hereditary colon cancer - a basis for prevention? , 2000, European journal of cancer.

[84]  J. Jiricny,et al.  Mismatch repair defects in cancer. , 2000, Current opinion in genetics & development.

[85]  S. Lippman,et al.  Advances in the development of retinoids as chemopreventive agents. , 2000, The Journal of nutrition.

[86]  E. Clipp,et al.  Current health behaviors and readiness to pursue life‐style changes among men and women diagnosed with early stage prostate and breast carcinomas , 2000, Cancer.

[87]  Weiya Ma,et al.  Inhibition of atypical PKC blocks ultraviolet‐induced AP‐1 activation by specifically inhibiting ERKs activation , 2000, Molecular carcinogenesis.

[88]  V. Steele,et al.  Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. , 2000, Carcinogenesis.

[89]  W. Willett,et al.  Postmenopausal estrogens--opposed, unopposed, or none of the above. , 2000, JAMA.

[90]  R. Hoover,et al.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000, JAMA.

[91]  Anne M Kavanagh,et al.  Hormone replacement therapy and accuracy of mammographic screening , 2000, The Lancet.

[92]  R. Jackson,et al.  Prostate cancer and dietary carotenoids. , 2000, American journal of epidemiology.

[93]  Peter C Gøtzsche,et al.  Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.

[94]  S. Lippman,et al.  Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. , 2000, Journal of the National Cancer Institute.

[95]  G. Rennert,et al.  Utilization of K‐ras mutations identified in stool DNA for the early detection of colorectal cancer , 2000, Journal of cellular biochemistry. Supplement.

[96]  D. Leffell.  The scientific basis of skin cancer. , 2000, Journal of the American Academy of Dermatology.

[97]  H. D. de Koning.  Assessment of nationwide cancer-screening programmes. , 2000, Lancet.

[98]  C. Cockerell,et al.  Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). , 2000, Journal of the American Academy of Dermatology.

[99]  S. Salasche,et al.  Epidemiology of actinic keratoses and squamous cell carcinoma. , 2000, Journal of the American Academy of Dermatology.

[100]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[101]  Weiya Ma,et al.  PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer. , 1999, Anticancer research.

[102]  C. Sigman,et al.  Cancer chemoprevention: progress and promise. , 1999, European journal of cancer.

[103]  J. Minna,et al.  Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. , 1999, Journal of the National Cancer Institute.

[104]  P. Bartels,et al.  Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents. , 1999, Journal of clinical pathology.

[105]  P. Møller,et al.  Familial endometrial cancer in female carriers of MSH6 germline mutations , 1999, Nature Genetics.

[106]  J. Schoggins,et al.  Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. , 1999, Carcinogenesis.

[107]  M. Pike,et al.  Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA , 1999, The Lancet.

[108]  J. Lin,et al.  Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. , 1999, Biochemical pharmacology.

[109]  J Benichou,et al.  Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.

[110]  Z. Dong,et al.  Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. , 1999, Cancer research.

[111]  V. Jordan,et al.  Tamoxifen: too much of a good thing? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  T. Mäkelä,et al.  Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[113]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis , 1999, Molecular carcinogenesis.

[114]  D B Kopans,et al.  Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.

[115]  M. Stolte,et al.  Frequent 4‐bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients , 1999, Genes, chromosomes & cancer.

[116]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[117]  R. Lamerz,et al.  Tumour markers in prostate cancer: EGTM recommendations , 1999 .

[118]  R. Scott,et al.  Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer , 1999, Cancer.

[119]  T. Sellers,et al.  Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. , 1999, JAMA.

[120]  K. Griffiths,et al.  Diet and Its Preventive Role in Prostatic Disease , 1999, European Urology.

[121]  V. Steele,et al.  Chemoprevention of Prostate Cancer: Concepts and Strategies , 1999, European Urology.

[122]  A. Zlotta,et al.  Clinical Evolution of Prostatic Intraepithelial Neoplasia , 1999, European Urology.

[123]  D. Peehl.  Vitamin D and Prostate Cancer Risk , 1999, European Urology.

[124]  J. Estève,et al.  Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme , 1999, Journal of medical screening.

[125]  A. Kubba.  Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward? , 1999, European journal of cancer.

[126]  M. Moyad.  Soy, disease prevention, and prostate cancer. , 1999, Seminars in urologic oncology.

[127]  D. Trump,et al.  Vitamin D in the prevention and treatment of prostate cancer. , 1999, Seminars in urologic oncology.

[128]  C C Sigman,et al.  Lipoxygenase inhibitors as potential cancer chemopreventives. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[129]  E. Gerner,et al.  Development of difluoromethylornithine (DFMO) as a chemoprevention agent. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[130]  S. Lam,et al.  Sex-related differences in bronchial epithelial changes associated with tobacco smoking. , 1999, Journal of the National Cancer Institute.

[131]  S. Seal,et al.  Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. , 1999, Gastroenterology.

[132]  S B Kaye,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0312 Retinoids: present role and future potential , 2022 .

[133]  W. Willett,et al.  Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. , 1999, Cancer research.

[134]  J. Cuzick,et al.  Drop-outs in tamoxifen prevention trials , 1999, The Lancet.

[135]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[136]  P. Crowell,et al.  Prevention and therapy of cancer by dietary monoterpenes. , 1999, The Journal of nutrition.

[137]  E. Giovannucci,et al.  Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. , 1999, Journal of the National Cancer Institute.

[138]  R. Hoover,et al.  Estrogen replacement therapy and breast cancer survival in a large screening study. , 1999, Journal of the National Cancer Institute.

[139]  T. C. McLoud,et al.  Lung carcinoma. , 1999, Clinics in chest medicine.

[140]  T. Mack,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[141]  Y. Hara,et al.  Antimutagenic and anticarcinogenic activity of tea polyphenols. , 1999, Mutation research.

[142]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[143]  A. Castonguay,et al.  Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. , 1998, Cancer research.

[144]  S. Lippman,et al.  Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. , 1998, Journal of the National Cancer Institute.

[145]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[146]  J. Rüschoff,et al.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[147]  M. Helvie,et al.  Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method. , 1998, Radiology.

[148]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[149]  P. Boyle,et al.  Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group. , 1998, British Journal of Cancer.

[150]  E. Rimm,et al.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. , 1998, Journal of the National Cancer Institute.

[151]  N. Levine,et al.  Role of retinoids in skin cancer treatment and prevention. , 1998, Journal of the American Academy of Dermatology.

[152]  K. Pritchard.  Is tamoxifen effective in prevention of breast cancer? , 1998, The Lancet.

[153]  A. Castonguay,et al.  Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. , 1998, Experimental lung research.

[154]  S. Hodgson,et al.  A survey of phenotypic features in juvenile polyposis. , 1998, Journal of medical genetics.

[155]  L. Aaltonen,et al.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.

[156]  J. Mathers,et al.  Diet and cancer prevention: the Concerted Action Polyp Prevention (CAPP) Studies , 1998, Proceedings of the Nutrition Society.

[157]  N. Swanson,et al.  Clinical and histologic trends of melanoma. , 1998, Journal of the American Academy of Dermatology.

[158]  B. Turnbull,et al.  Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. , 1998, British journal of urology.

[159]  Y. Yano,et al.  The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in mice based on the regulation of polyamine metabolism. , 1998, Cancer letters.

[160]  I. Lubensky,et al.  Germline PTEN/MMAC1/TEP1 mutations and association with gastrointestinal manifestations in Cowden disease , 1998 .

[161]  E. Constant,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. , 1998 .

[162]  D. Bonn.  Vitamin E may reduce prostate-cancer incidence , 1998, The Lancet.

[163]  J. Voorhees,et al.  Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. , 1998, The Journal of clinical investigation.

[164]  Weiya Ma,et al.  Inhibition of ultraviolet C irradiation-induced AP-1 activity by aspirin is through inhibition of JNKs but not erks or P38 MAP kinase. , 1998, International journal of oncology.

[165]  D. Whynes,et al.  Faecal occult blood screening for colorectal cancer: is it cost-effective? , 1998, Health economics.

[166]  G A Colditz,et al.  Calcium and fructose intake in relation to risk of prostate cancer. , 1998, Cancer research.

[167]  A. Kong,et al.  Molecular Mechanisms of c-Jun N-terminal Kinase-mediated Apoptosis Induced by Anticarcinogenic Isothiocyanates* , 1998, The Journal of Biological Chemistry.

[168]  C J Baines,et al.  The Gothenburg breast screening trial , 1997, Cancer.

[169]  S. Ripatti,et al.  Prostate Cancer and Supplementation With -Tocopherol and -Carotene: Incidence and Mortality in a Controlled Trial , 1998 .

[170]  I. Wistuba,et al.  Molecular Abnormalities in the Sequential Development of Lung Carcinoma , 1998 .

[171]  S. Lam,et al.  Endoscopic Localization of Preneoplastic Lung Lesions , 1998 .

[172]  K. Picard,et al.  Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. , 1998, Nutrition and cancer.

[173]  G. Omenn.  Chemoprevention of lung cancer: the rise and demise of beta-carotene. , 1998, Annual review of public health.

[174]  R. Fletcher.  Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it? , 1998, The New England journal of medicine.

[175]  A. Malkinson,et al.  Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. , 1998, Experimental lung research.

[176]  L. Aaltonen.  Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[177]  S. Shapiro,et al.  Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. , 1998, International journal of epidemiology.

[178]  K. Miyazono,et al.  HNPCC associated with germline mutation in the TGF-beta type II receptor gene. , 1998, Nature genetics.

[179]  I. Tomlinson,et al.  Modifier genes in humans: strategies for identification , 1998, European Journal of Human Genetics.

[180]  V. Steele,et al.  Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. , 1997, Cancer research.

[181]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[182]  S. Feig,et al.  Increased benefit from shorter screening mammography intervals for women ages 40‐49 years , 1997, Cancer.

[183]  W. Fair,et al.  Cancer of the prostate: a nutritional disease? , 1997, Urology.

[184]  Weiya Ma,et al.  Direct Evidence for an Important Role of Sphingomyelinase in Ultraviolet-induced Activation of c-Jun N-Terminal Kinase* , 1997, The Journal of Biological Chemistry.

[185]  Weiya Ma,et al.  Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[186]  R. Estensen,et al.  Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice. , 1997, Carcinogenesis.

[187]  Jen-kun Lin,et al.  Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)‐epigallocatechin gallate in human A431 epidermoid carcinoma cells , 1997, Journal of cellular biochemistry.

[188]  T. Church,et al.  Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. , 1997, Journal of the National Cancer Institute.

[189]  J. Samet,et al.  Molecular damage in the bronchial epithelium of current and former smokers. , 1997, Journal of the National Cancer Institute.

[190]  B Palcic,et al.  Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. , 1997, Mayo Clinic proceedings.

[191]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[192]  K. Subbaramaiah,et al.  Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. , 1997, Cancer research.

[193]  J S Lee,et al.  Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.

[194]  Weiya Ma,et al.  Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[195]  R. Scott,et al.  Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis , 1997, Human Genetics.

[196]  Eero Pukkala,et al.  Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.

[197]  E. Thomson,et al.  Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .

[198]  I. Dreosti,et al.  Cancer biomarkers in the field of tea. , 1997, Cancer letters.

[199]  K. Subbaramaiah,et al.  Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. , 1997, Cancer research.

[200]  S. Self,et al.  Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. , 1997, Journal of the National Cancer Institute.

[201]  Håkan Jonsson,et al.  Excess Mortality from Breast Cancer in Relation to Mammography Screening in Northern Sweden , 1997, Journal of medical screening.

[202]  Szabó,et al.  Intermediate Markers and Molecular Genetics of Lung Carcinogenesis. , 1997, Cancer control : journal of the Moffitt Cancer Center.

[203]  N F Boyd,et al.  The review of randomization in the Canadian National Breast Screening Study. Is the debate over? , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[204]  B. Macmahon,et al.  Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[205]  D. Wilton.  The mechanism of malignancy associated changes , 1997 .

[206]  P. Payne.  Cytometric detection of nuclear features associated with pre-malignancy or malignancy in human bronchial specimens , 1997 .

[207]  J. Ranstam,et al.  Increasing incidence of and declining mortality from breast carcinoma , 1997, Cancer.

[208]  S. Lam,et al.  Molecular follow-up of a preinvasive bronchial lesion treated by 13-cis-retinoic acid. , 1997, Human pathology.

[209]  P. Ottino,et al.  Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. , 1997, Free radical biology & medicine.

[210]  A. Anagnostou,et al.  dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. , 1997, Nutrition and cancer.

[211]  I Andersson,et al.  Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. , 1997, Journal of the National Cancer Institute. Monographs.

[212]  T. Smyrk,et al.  An update of HNPCC (Lynch syndrome). , 1997, Cancer genetics and cytogenetics.

[213]  J. V. Bacus,et al.  Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents , 1997, Journal of cellular biochemistry. Supplement.

[214]  R. Hendrick,et al.  Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. , 1997, Journal of the National Cancer Institute. Monographs.

[215]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[216]  Weiya Ma,et al.  Ultraviolet B-induced Activated Protein-1 Activation Does Not Require Epidermal Growth Factor Receptor but Is Blocked by a Dominant Negative PKCλ/ι* , 1996, The Journal of Biological Chemistry.

[217]  A. Ziegler,et al.  Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. , 1996, The journal of investigative dermatology. Symposium proceedings.

[218]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[219]  R. Tarone,et al.  Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[220]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[221]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[222]  S. Lippman,et al.  Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[223]  S. Frankel,et al.  Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. , 1996, British Journal of Cancer.

[224]  T. Powles,et al.  The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[225]  M. Spitz,et al.  Lung carcinoma in former smokers , 1996, Cancer.

[226]  R. Lotan.  Retinoids in cancer chemoprevention , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[227]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[228]  R. Scott,et al.  Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. , 1996, Journal of medical genetics.

[229]  F. Pontén,et al.  Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. , 1996, Oncogene.

[230]  Z. Dong,et al.  Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. , 1996, Cancer research.

[231]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[232]  G. Petersen,et al.  Genetic testing and counseling in familial adenomatous polyposis. , 1996, Oncology.

[233]  R. Montironi,et al.  Precursors of prostatic cancer: progression, regression and chemoprevention. , 1996, European urology.

[234]  G. Omenn,et al.  Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. , 1996, IARC scientific publications.

[235]  G A Colditz,et al.  Intake of carotenoids and retinol in relation to risk of prostate cancer. , 1995, Journal of the National Cancer Institute.

[236]  L. Packer,et al.  Vitamin E: beyond antioxidant function. , 1995, The American journal of clinical nutrition.

[237]  David B. Holiday,et al.  Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. , 1995, The American journal of clinical nutrition.

[238]  H. Herschman,et al.  v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.

[239]  G. Stiff,et al.  Management of infantile polyposis syndrome. , 1995, Archives of disease in childhood.

[240]  H. Ananthaswamy,et al.  p53 GENE MUTATIONS AND PHOTOCARCINOGENESIS , 1995, Photochemistry and photobiology.

[241]  J. Jiricny,et al.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. , 1995, Science.

[242]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[243]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[244]  Y. Kubo,et al.  Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma. , 1995, The Journal of investigative dermatology.

[245]  B Palcic,et al.  Nuclear texture measurements in image cytometry. , 1995, Pathologica.

[246]  S. Feig,et al.  Estimation of currently attainable benefit from mammographic screening of women aged 40‐49 years , 1995, Cancer.

[247]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[248]  B. Bauduceau,et al.  [Association of Gardner syndrome and thyroid carcinoma]. , 1995, Presse medicale.

[249]  B Palcic,et al.  Malignancy-associated changes in bronchial epithelial cells in biopsy specimens. , 1995, Analytical and quantitative cytology and histology.

[250]  G. Cameron,et al.  High sun protection factor sunscreens in the suppression of actinic neoplasia. , 1995, Archives of dermatology.

[251]  Robin Marks,et al.  An overview of skin cancers , 1995, Cancer.

[252]  S. Rubin,et al.  Efficacy of screening mammography. A meta-analysis. , 1995, JAMA.

[253]  B. G. Sanders,et al.  RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. , 1995, Nutrition and cancer.

[254]  H. Mukhtar.  Skin Cancer: Mechanisms and Human Relevance , 1994 .

[255]  D. Bishop,et al.  Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. , 1994, Genomics.

[256]  A. Fanjul,et al.  A new class of retinoids with selective inhibition of AP-1 inhibits proliferation , 1994, Nature.

[257]  S. Feig.  Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years. , 1994, Radiology.

[258]  F. Sacks,et al.  Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. , 1994, Journal of lipid research.

[259]  E. Healy,et al.  Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants. , 1994, The Journal of investigative dermatology.

[260]  D. Alberts,et al.  Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. , 1994, Cancer letters.

[261]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[262]  N. Park,et al.  Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. , 1994, Oncogene.

[263]  W. Weber,et al.  Colorectal cancer: lessons for genetic counselling and care for families , 1994, Clinical genetics.

[264]  G. Swanson.  May we agree to disagree, or how do we develop guidelines for breast cancer screening in women? , 1994, Journal of the National Cancer Institute.

[265]  S. Lippman,et al.  Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[266]  A. Halpern,et al.  Effects of topical tretinoin on dysplastic nevi. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[267]  M N Gould,et al.  Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. , 1994, Biochemical pharmacology.

[268]  Y. Kubo,et al.  p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. , 1994, The Journal of investigative dermatology.

[269]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[270]  N. S. Mcnutt,et al.  Abnormalities of p53 protein expression in cutaneous disorders. , 1994, Archives of dermatology.

[271]  Z. Dong,et al.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[272]  R. Agarwal,et al.  Green tea and skin--anticarcinogenic effects. , 1994, The Journal of investigative dermatology.

[273]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[274]  G. Thomas,et al.  Alleles of the APC gene: An attenuated form of familial polyposis , 1993, Cell.

[275]  J. Hardcastle,et al.  Change towards earlier stage at presentation of colorectal cancer , 1993, The British journal of surgery.

[276]  N. Boyd,et al.  A critical appraisal of the Canadian National Breast Cancer Screening Study. , 1993, Radiology.

[277]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[278]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[279]  S. Feig,et al.  The Canadian National Breast Screening Study: a critical review. , 1993, AJR. American journal of roentgenology.

[280]  F. Giardiello,et al.  Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. , 1993, Gut.

[281]  P. Taylor,et al.  Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. , 1993, Journal of the National Cancer Institute.

[282]  M. Ueda,et al.  Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. , 1993, Archives of dermatology.

[283]  T. Beaty,et al.  Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.

[284]  R. Estensen,et al.  Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. , 1993, Carcinogenesis.

[285]  C. Smart,et al.  The canadian national breast screening study. An appraisal and implications for early detection policy , 1993, Cancer.

[286]  Z. Y. Wang,et al.  Tea and cancer. , 1993, Journal of the National Cancer Institute.

[287]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[288]  C. Campbell,et al.  Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. , 1993, Cancer research.

[289]  F. Macrae,et al.  Evaluation of new occult blood tests for detection of colorectal neoplasia. , 1993, Gastroenterology.

[290]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[291]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[292]  C. Perez.  Nonmelanoma cancers of the skin. , 1993, The New England journal of medicine.

[293]  L. Packer,et al.  Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. , 1993, Biochimica et biophysica acta.

[294]  N. Basset-Seguin,et al.  p53 gene mutations in human epithelial skin cancers. , 1993, Oncogene.

[295]  D. Lane,et al.  p53 protein expression in benign and malignant skin tumours , 1993, The British journal of dermatology.

[296]  R. Weber,et al.  Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. , 1993, The New England journal of medicine.

[297]  H J Burhenne,et al.  Canadian National Breast Screening Study. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[298]  V. Semiglazov,et al.  Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. , 1993, European journal of cancer.

[299]  D. Lane,et al.  High levels of p53 protein in UV-irradiated normal human skin. , 1993, Oncogene.

[300]  G. Schwartz,et al.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation , 1992, Cancer.

[301]  R. Scott,et al.  Hereditary conditions in which the loss of heterozygosity may be important. , 1992, Mutation research.

[302]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[303]  R. Agarwal,et al.  Green tea in chemoprevention of cancer. , 1992, Comprehensive therapy.

[304]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[305]  Y. Urano,et al.  Immunohistological analysis of P53 expression in human skin tumors. , 1992, Journal of dermatological science.

[306]  P. G. Prioleau,et al.  Overexpression of p53 protein in basal cell carcinomas of human skin. , 1992, The American journal of pathology.

[307]  R. Stern,et al.  Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. , 1992, JAMA.

[308]  P. H. Mckee,et al.  Mutant p53 Protein Is Expressed in Bowen's Disease , 1992, The American Journal of dermatopathology.

[309]  K. Kinzler,et al.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[310]  B. Hanusa,et al.  New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. , 1992, Journal of the American Academy of Dermatology.

[311]  L. Booker,et al.  The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. , 1992, British Journal of Cancer.

[312]  V. Steele,et al.  Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. , 1992, Cancer research.

[313]  Parkin Dm,et al.  Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .

[314]  A. Miller,et al.  Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[315]  R. Moy,et al.  Biology of cutaneous squamous cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[316]  W. Zgliczyński,et al.  Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. , 1992, Journal of endocrinological investigation.

[317]  J. Kaldor,et al.  The benefits and risks of mammographic screening for breast cancer. , 1992, Epidemiologic reviews.

[318]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[319]  A. Jones.  Prevention of breast cancer , 1991, Current opinion in oncology.

[320]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[321]  F. Giardiello,et al.  Risk of hepatoblastoma in familial adenomatous polyposis. , 1991, The Journal of pediatrics.

[322]  L. Verschoor,et al.  Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women : Gastroenterology 1991 100/2 (482–488) , 1991 .

[323]  P. Ueland,et al.  Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. , 1991, Cancer research.

[324]  S. Kliewer,et al.  Retinoic acid is a negative regulator of AP-1-responsive genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[325]  J E Hewett,et al.  Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. , 1991, Archives of dermatology.

[326]  A. Miller,et al.  The role of the nurse-examiner in the National Breast Screening Study. , 1991, Canadian journal of public health = Revue canadienne de sante publique.

[327]  K. Ho,et al.  Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.

[328]  C. Muir,et al.  The epidemiology of prostatic cancer. Geographical distribution and time-trends. , 1991, Acta oncologica.

[329]  W. Pierceall,et al.  Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas , 1991, Molecular carcinogenesis.

[330]  K. Helzlsouer,et al.  Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. , 1991, The American journal of clinical nutrition.

[331]  P. Chambon,et al.  Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. , 1990, The EMBO journal.

[332]  L. Watson,et al.  Survival in patients with large-bowel cancer , 1990, Diseases of the colon and rectum.

[333]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[334]  B. Polk,et al.  Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. , 1990, Journal of the National Cancer Institute.

[335]  P. Donnan,et al.  Edinburgh trial of screening for breast cancer , 1990, The Lancet.

[336]  R. Lotan,et al.  Biomarkers as intermediate end points in chemoprevention trials. , 1990, Journal of the National Cancer Institute.

[337]  P. Lenner.  The excess mortality rate. A useful concept in cancer epidemiology. , 1990, Acta oncologica.

[338]  C. Boone,et al.  Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. , 1990, Cancer research.

[339]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[340]  L M Schuman,et al.  Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. , 1989, Gastroenterology.

[341]  A. Wiltshire.  FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER , 1989, The Lancet.

[342]  R Holland,et al.  The occurrence of interval cancers in the Nijmegen screening programme. , 1989, British Journal of Cancer.

[343]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[344]  G. Vooijs,et al.  Diagnostic significance of "severe dysplasia" in sputum cytology. , 1988, Acta cytologica.

[345]  R. Madhubala,et al.  Control of ornithine decarboxylase activity in alpha-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. , 1988, The Journal of biological chemistry.

[346]  A. Azzi,et al.  Vitamin E inhibits protein kinase C activity. , 1988, Biochemical and biophysical research communications.

[347]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[348]  R. Peto,et al.  Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. , 1988, American journal of epidemiology.

[349]  A. Bendich,et al.  Free radical tissue damage: protective role of antioxidant nutrients 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[350]  A J Krush,et al.  Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.

[351]  A. Verma,et al.  Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. , 1987, Cancer research.

[352]  R. Sutherland,et al.  Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. , 1987, Journal of steroid biochemistry.

[353]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[354]  Stefano Ciatto,et al.  A case‐control study of the efficacy of a non‐randomized breast cancer screening program in florence (Italy) , 1986, International journal of cancer.

[355]  F. Meyskens,et al.  Role of topical tretinoin in melanoma and dysplastic nevi. , 1986, Journal of the American Academy of Dermatology.

[356]  N. J. Pressman,et al.  Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[357]  V. Fazio,et al.  Desmoid Tumors in Familial Polyposis Coli , 1986, Annals of surgery.

[358]  P. Band,et al.  Reversibility of bronchial marked atypia: implication for chemoprevention. , 1986, Cancer detection and prevention.

[359]  J. Haybittle,et al.  SURVIVAL IN BREAST CANCER , 1984, The Lancet.

[360]  J. Hendriks,et al.  REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY First Results of the Nijmegen Project, 1975 - 1981 , 1984, The Lancet.

[361]  E. A. Baanders-van Halewijn,et al.  The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. , 1984, Journal of chronic diseases.

[362]  A. Smith.  Trends in Cancer Incidence , 1982, British Journal of Cancer.

[363]  G. Saccomanno.  Carcinoma in Situ of the Lung: Its Development, Detection, and Treatment , 1982 .

[364]  S. Shapiro,et al.  Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.

[365]  L. Baker,et al.  Breast cancer detection demonstration project: Five‐year summary report , 1982, CA: a cancer journal for clinicians.

[366]  K. Covington,et al.  Surgical Experience with Carcinoma of the Colon and Rectum , 1982, Annals of surgery.

[367]  U. Ohman.  Colorectal carcinoma--trends and results over a 30-year period. , 1982, Diseases of the colon and rectum.

[368]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[369]  K. Hou‐Jensen,et al.  Metastases in dermatological patients with squamous cell carcinoma. , 1979, Archives of dermatology.

[370]  L. Garfinkel,et al.  Histologic findings in the tracheobronchial tree of uranium miners and non‐miners with lung cancer , 1978, Cancer.

[371]  Nita Barrow,et al.  REPORT ON WORKSHOP A , 1978 .

[372]  M. Lippman,et al.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.

[373]  O. Auerbach,et al.  Development of carcinoma of the lung as reflected in exfoliated cells , 1974, Cancer.

[374]  J. Wedderburn.  Selenium and cancer. , 1972, New Zealand veterinary journal.

[375]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .

[376]  E. Gardner.  Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. , 1962, American journal of human genetics.

[377]  H. Jeghers,et al.  Vitamin E. , 1959, The Practitioner.